Filing Details
- Accession Number:
- 0001192482-11-000021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-04 16:31:30
- Reporting Period:
- 2011-01-27
- Filing Date:
- 2011-02-04
- Accepted Time:
- 2011-02-04 16:31:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
352998 | Igi Laboratories Inc | IG | Biological Products, (No Disgnostic Substances) (2836) | 010355758 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1358088 | Nadya Lawrence | C/O Igi Laboratories 105 Lincoln Avenue Buena NJ 08310 | Exec. Vp-Sales And Marketing | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-01-27 | 5,000 | $0.52 | 15,928 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-01-27 | 5,000 | $1.75 | 10,928 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2011-01-27 | 5,000 | $0.00 | 5,000 | $0.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
240,000 | 2011-12-27 | No | 4 | M | Direct |
Footnotes
- The options vested immediately.